It’s a Great Clinical Trial Assay
While there are many great tools and technologies available to support drug development, the number of platforms used for CDx development remains very limited.
Is It Validated?
NeoGenomics has a menu of >600 assays across many different technologies and approaches.
Liquid Biopsy Testing for PIK3CA Mutation
For years, researchers have looked into liquid biopsy as a potentially useful tool to help Health Care Providers assess a patient’s response to treatment, monitor cancer recurrence and even detect
A spotlight on CDx development
NeoGenomics will share several posts focusing on CDx development.
Being Comprehensive in Hematologic Malignancies
The need for comprehensive testing seems obvious in the context of working up most cases of hematologic malignancies.
Improving Diagnosis of Barrett’s Esophagus
Esophageal cancer, while relatively uncommon, has risen dramatically over the past several decades.
Expert approaches to resolving challenging areas in diagnostic pathology
The past decade has seen considerable diagnostic advances distinguishing classic Hodgkin lymphoma (CHL) from other lymphoma mimics.
MultiOmyx 101: An Introduction to Multiplexing Technology
Cancer claims more than half a million lives each year in the United States alone.
